SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hanna S. Lindgren, Merve Demirbugen, Filip Bergqvist, Emma L. Lane, Stephen B. Dunnett, The effect of additional noradrenergic and serotonergic depletion on a lateralised choice reaction time task in rats with nigral 6-OHDA lesions, Experimental Neurology, 2014, 253, 52

    CrossRef

  2. 2
    Mohammad M. Herzallah, Ahmed A. Moustafa, Joman Y. Natsheh, Omar A. Danoun, Jessica R. Simon, Yasin I. Tayem, Mahmud A. Sehwail, Ivona Amleh, Issam Bannoura, Georgios Petrides, Catherine E. Myers, Mark A. Gluck, Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder, Journal of Affective Disorders, 2013, 151, 2, 484

    CrossRef

  3. 3
    Philippe Huot, Susan H. Fox, The serotonergic system in motor and non-motor manifestations of Parkinson’s disease, Experimental Brain Research, 2013, 230, 4, 463

    CrossRef

  4. 4
    Hanna S. Lindgren, Stephen B. Dunnett, Cognitive dysfunction and depression in Parkinson’s disease: what can be learned from rodent models?, European Journal of Neuroscience, 2012, 35, 12
  5. 5
    Hanna S. Lindgren, Mariah J. Lelos, Stephen B. Dunnett, Do alpha-synuclein vector injections provide a better model of Parkinson's disease than the classic 6-hydroxydopamine model?, Experimental Neurology, 2012, 237, 1, 36

    CrossRef

  6. You have free access to this content6
    Paul E. Polak, Sergey Kalinin, David Braun, Anthony Sharp, Shao X. Lin, Douglas L. Feinstein, The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus, Journal of Neurochemistry, 2012, 121, 2
  7. 7
    David J. Brooks, Nicola Pavese, Imaging biomarkers in Parkinson's disease, Progress in Neurobiology, 2011, 95, 4, 614

    CrossRef

  8. 8
    P. E. Polak, S. Kalinin, D. L. Feinstein, Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis, Brain, 2011, 134, 3, 665

    CrossRef

  9. 9
    Sonny K.H. Tan, Henrike Hartung, Trevor Sharp, Yasin Temel, Serotonin-dependent depression in Parkinson’s disease: A role for the subthalamic nucleus?, Neuropharmacology, 2011, 61, 3, 387

    CrossRef

  10. 10
    Philippe Huot, Susan H. Fox, Jonathan M. Brotchie, The serotonergic system in Parkinson's disease, Progress in Neurobiology, 2011, 95, 2, 163

    CrossRef

  11. 11
    John Meitzen, Jessie I. Luoma, Christopher M. Stern, Paul G. Mermelstein, β1-Adrenergic receptors activate two distinct signaling pathways in striatal neurons, Journal of Neurochemistry, 2011, 116, 6
  12. 12
    Jau-Shin Lou, Physical and Mental Fatigue in Parkinsonʼs Disease, Drugs & Aging, 2009, 26, 3, 195

    CrossRef

  13. 13
    Jose L. M. Madrigal, Sergey Kalinin, Jill C. Richardson, Douglas L. Feinstein, Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta, Journal of Neurochemistry, 2007, 103, 5
  14. 14
    K.S. Rommelfanger, D. Weinshenker, Norepinephrine: The redheaded stepchild of Parkinson's disease, Biochemical Pharmacology, 2007, 74, 2, 177

    CrossRef

  15. 15
    B. Ballanger, R. Gil, M. Audiffren, M. Desmurget, Perceptual factors contribute to akinesia in Parkinson’s disease, Experimental Brain Research, 2007, 179, 2, 245

    CrossRef

  16. 16
    Leonid Yavich, Pekka Jäkälä, Heikki Tanila, Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in α-synuclein knockout and A30P transgenic mice, Journal of Neurochemistry, 2006, 99, 3
  17. 17
    Sergey Kalinin, Paul E. Polak, Jose L. M. Madrigal, Vitaliy Gavrilyuk, Anthony Sharp, Neelima Chauhan, Marc Marien, Francis Colpaert, Douglas L. Feinstein, Beta-Amyloid-Dependent Expression of NOS2in Neurons: Prevention by an α2-Adrenergic Antagonist, Antioxidants & Redox Signaling, 2006, 8, 5-6, 873

    CrossRef

  18. 18
    Makoto Sasaki, Eri Shibata, Koujiro Tohyama, Junko Takahashi, Kotaro Otsuka, Kuniaki Tsuchiya, Satoshi Takahashi, Shigeru Ehara, Yasuo Terayama, Akio Sakai, Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson??s disease, NeuroReport, 2006, 17, 11, 1215

    CrossRef

  19. 19
    Samuel G Speciale, MPTP, Neurotoxicology and Teratology, 2002, 24, 5, 607

    CrossRef

  20. 20
    N. Hishikawa, Y. Hashizume, M. Yoshida, G. Sobue, Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease, Neuropathology and Applied Neurobiology, 2001, 27, 5
  21. 21
    Peter Åkerud, Jordi Alberch, Susanna Eketjäll, Joseph Wagner, Ernest Arenas, Differential Effects of Glial Cell Line-Derived Neurotrophic Factor and Neurturin on Developing and Adult Substantia Nigra Dopaminergic Neurons, Journal of Neurochemistry, 1999, 73, 1
  22. 22
    Shuang Yong Ma, Juha O. Rinne, Yrjö Collan, Matias Röyttä, Urpo K. Rinne, A quantitative morphometrical study of neuron degeneration in the substantia nigra in Parkinson's disease, Journal of the Neurological Sciences, 1996, 140, 1-2, 40

    CrossRef

  23. 23
    B. Naudin, J.-J. Bonnet, J. Costentin, Acutel-DOPA pretreatment potentiates 6-hydroxydopamine-induced toxic effects on nigro-striatal dopamine neurons in mice, Brain Research, 1995, 701, 1-2, 151

    CrossRef

  24. 24
    Ernest Arenas, Miles Trupp, Peter Åkerud, Carlos F. Ibáñez, GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo, Neuron, 1995, 15, 6, 1465

    CrossRef

  25. 25
    Stéphane Lehéricy, Jean-Philippe Brandel, Etienne C. Hirsch, Philippe Anglade, Joao Villares, Daniel Scherman, Charles Duyckaerts, France Javoy-Agid, Yves Agid, Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography, Brain Research, 1994, 659, 1-2, 1

    CrossRef

  26. 26
    Patrick Vermersch, André Delacourte, France Javoy-Agid, Jean-Jacques Hauw, Yves Agid, Dementia in Parkinson's disease: Biochemical evidence for cortical involvement using the immunodetection of abnormal tau proteins, Annals of Neurology, 1993, 33, 5
  27. 27
    Albert Gjedde, Gabriel C. Léger, Paul Cumming, Yoshifumi Yasuhara, Alan C. Evans, Mark Guttman, Hiroto Kuwabara, Striatal L-DOPA Decarboxylase Activity in Parkinson's Disease In Vivo: Implications for the Regulation of Dopamine Synthesis, Journal of Neurochemistry, 1993, 61, 4
  28. 28
    B. Lach, D. Grimes, B. Benoit, A. Minkiewicz-Janda, Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material, Acta Neuropathologica, 1992, 83, 4, 352

    CrossRef

  29. 29
    L. Wisniowski, R. M. Ridley, H. F. Baker, A. Fine, Tyrosine hydroxylase-immunoreactive neurons in the nucleus basalis of the common marmoset (Callithrix jacchus), Journal of Comparative Neurology, 1992, 325, 3
  30. 30
    Patricia Gaspar, Charles Duyckaerts, Chantal Alvarez, France Javoy-Agid, Brigitte Berger, Alterations of dopaminergic and noradrenergic innervations in motor cortex in parkinson's disease, Annals of Neurology, 1991, 30, 3
  31. 31
    K.G. Baker, G.M. Halliday, J.-P. Hornung, L.B. Geffen, R.G.H. Cotton, I. To¨rk, Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus, Neuroscience, 1991, 42, 3, 757

    CrossRef

  32. 32
    Per Wester, Ulrica Bergström, Arne Brun, Sten Jagell, Bertil Karlsson, Anders Eriksson, Monoaminergic dysfunction in Sjögren-Larsson syndrome, Molecular and Chemical Neuropathology, 1991, 15, 1, 13

    CrossRef

  33. 33
    Kurt A. Jellinger, Pathology of Parkinson’s disease, Molecular and Chemical Neuropathology, 1991, 14, 3, 153

    CrossRef

  34. 34
    H. Braak, E. Braak, Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles, and neuropil threads in the cerebral cortex, Journal of Neural Transmission - Parkinson's Disease and Dementia Section, 1990, 2, 1, 45

    CrossRef

  35. 35
    G.M. Halliday, P.C. Blumbergs, R.G.H. Cotton, W.W. Blessing, L.B. Geffen, Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease, Brain Research, 1990, 510, 1, 104

    CrossRef

  36. 36
    G. M. Halliday, Y. W. Li, P. C. Blumbergs, T. H. Joh, R. G. H. Cotton, P. R. C. Howe, W. W. Blessing, L. B. Geffen, Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease, Annals of Neurology, 1990, 27, 4
  37. 37
    V. Chan-Palay, E. Asan, Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression, Journal of Comparative Neurology, 1989, 287, 3
  38. 38
    Yves Agid, Pascale Cervera, Etienne Hirsch, France Javoy-Agid, Stéphane Lehericy, Rita Raisman, Merle Ruberg, Biochemistry of Parkinson's disease 28 years later: A critical review, Movement Disorders, 1989, 4, S1
  39. 39
    Antonio Giampalmo, Dionigia Buffa, Angela C. Quaglia, Carlo M. Pesce, Common senile degeneration and degenerative diseases of senility and pre-senility of the brain: A perspective, Human Pathology, 1989, 20, 1, 7

    CrossRef

  40. 40
    V. Chan-Palay, E. Asan, Quantitation of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression, Journal of Comparative Neurology, 1989, 287, 3
  41. 41
    Jean Lud Cadet, A unifying theory of movement and madness: Involvement of free radicals in disorders of the isodendritic core of the brainstem, Medical Hypotheses, 1988, 27, 1, 59

    CrossRef

  42. 42
    Barry J. Everitt, Taina E. Sirkiä, Angela C. Roberts, Graham H. Jones, Trevor W. Robbins, Distribution and some projections of cholinergic neurons in the brain of the common marmoset, Callithrix jacchus, Journal of Comparative Neurology, 1988, 271, 4
  43. 43
    K. Jellinger, D. Armstrong, H. Y. Zoghbi, A. K. Percy, Neuropathology of Rett syndrome, Acta Neuropathologica, 1988, 76, 2, 142

    CrossRef

  44. 44
    P. BRUNDIN, R. E. STRECKER, O. LINDVALL, O. ISACSON, O. G. NILSSON, G. BARBIN, A. PROCHIANTZ, C. FORNI, A. NIEOULLON, H. WIDNER, F. H. GAGE, A. BJÖRKLUND, Intracerebral Grafting of Dopamine Neurons, Annals of the New York Academy of Sciences, 1987, 495, 1
  45. 45
    John D. Salamone, Behavioural functions of nucleus basalis magnocellularis and its relationship to dementia, Trends in Neurosciences, 1986, 9, 256

    CrossRef

  46. 46
    Kurt Jellinger, Franz Seitelberger, John M. Opitz, James F. Reynolds, Neuropathology of rett syndrome, American Journal of Medical Genetics, 1986, 25, S1
  47. 47
    J.M. Candy, E.K. Perry, R.H. Perry, J.A. Court, A.E. Oakley, J.A. Edwardson, Aging of the Brain and Alzheimer's Disease, 1986,

    CrossRef

  48. 48
    David M. Mann, Commentary on review by D. M. Gash, T. J. Collier and J. R. Sladek the application of neural transplantation to degenerative diseases of the human nervous system, Neurobiology of Aging, 1985, 6, 2, 160

    CrossRef

  49. 49
    P. Gaspar, F. Gray, Dementia in idiopathic Parkinson's disease, Acta Neuropathologica, 1984, 64, 1, 43

    CrossRef

  50. 50
    Steven H. Robison, Walter G. Bradley, DNA damage and chronic neuronal degenerations, Journal of the Neurological Sciences, 1984, 64, 1, 11

    CrossRef

  51. 51
    F. Tagliavini, G. Pilleri, C. Bouras, J. Constantinidis, The basal nucleus of Meynert in idiopathic Parkinson's disease, Acta Neurologica Scandinavica, 1984, 70, 1
  52. 52
    Susan H. Fox, Jonathan M. Brotchie, Non-Dopaminergic Approaches to the Treatment of Parkinson's Disease,